122 related articles for article (PubMed ID: 38378357)
1. Dietary composition and its association with metabolic dysfunction-associated fatty liver disease among Chinese adults: A cross-sectional study.
Niu Z; Liu J; Peng H; Wu X; Zheng X; Yao S; Xu C
Arab J Gastroenterol; 2024 May; 25(2):205-213. PubMed ID: 38378357
[TBL] [Abstract][Full Text] [Related]
2. Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease.
Guo B; Guo Y; Nima Q; Feng Y; Wang Z; Lu R; Baimayangji ; Ma Y; Zhou J; Xu H; Chen L; Chen G; Li S; Tong H; Ding X; Zhao X;
J Hepatol; 2022 Mar; 76(3):518-525. PubMed ID: 34883157
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
4. Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study.
Xie X; Guo B; Xiao X; Yin J; Wang Z; Jiang X; Li J; Long L; Zhou J; Zhang N; Zhang Y; Chen T; Kangzhuo B; Zhao X
BMC Public Health; 2022 Jan; 22(1):118. PubMed ID: 35038997
[TBL] [Abstract][Full Text] [Related]
5. The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction.
Lee SB; Jin MH; Yoon JH
Sci Rep; 2024 Mar; 14(1):6714. PubMed ID: 38509247
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Early-Life Exposure to Famine and Risk of Metabolic Associated Fatty Liver Disease in Chinese Adults.
Liu J; Wang G; Wu Y; Guan Y; Luo Z; Zhao G; Jiang Y
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836318
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes.
Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
Liver Int; 2023 Nov; 43(11):2445-2454. PubMed ID: 37387519
[TBL] [Abstract][Full Text] [Related]
9. Associations of polychlorinated biphenyls and organochlorine pesticides with metabolic dysfunction-associated fatty liver disease among Chinese adults: Effect modification by lifestyle.
Liu Q; Fan G; Bi J; Qin X; Fang Q; Wu M; Mei S; Wan Z; Lv Y; Song L; Wang Y
Environ Res; 2024 Jan; 240(Pt 2):117507. PubMed ID: 37918764
[TBL] [Abstract][Full Text] [Related]
10. [Case-control study of the relationship between dietary fatty acids intake and non-alcoholic fatty liver disease in Nanping City, 2015-2017].
Chen B; Yan J; Pan X; Li Y; Liu W; Peng X
Wei Sheng Yan Jiu; 2019 Jul; 48(4):552-559. PubMed ID: 31601335
[TBL] [Abstract][Full Text] [Related]
11. Association of Diet Quality with Metabolic (Dysfunction) Associated Fatty Liver Disease in Veterans in Primary Care.
Heredia NI; Thrift AP; Ramsey DJ; Loomba R; El-Serag HB
Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299561
[TBL] [Abstract][Full Text] [Related]
12. The relationship between vitamin K and metabolic dysfunction-associated fatty liver disease among the United States population: National Health and Nutrition Examination Survey 2017-2018.
Wang X; Zhang W; Huang J; Li H; Gao J
Front Nutr; 2023; 10():1086477. PubMed ID: 37305083
[TBL] [Abstract][Full Text] [Related]
13. Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study.
Hu Q; Chen Y; Bao T; Huang Y
Ren Fail; 2022 Dec; 44(1):1996-2005. PubMed ID: 36374233
[TBL] [Abstract][Full Text] [Related]
14. Association of Stroke With Metabolic Dysfunction-Associated Fatty Liver Disease With and Without CKD.
Li Y; Wu S; Gao J; Zhang Y; Zuo Y; Tian X; Chen S; Xing A; Wang A; He Y
Am J Kidney Dis; 2024 Apr; 83(4):477-488. PubMed ID: 37838141
[TBL] [Abstract][Full Text] [Related]
15. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease.
Wu T; Ye J; Shao C; Li F; Lin Y; Ma Q; Wang W; Feng S; Zhong B
Front Endocrinol (Lausanne); 2021; 12():691556. PubMed ID: 34899591
[TBL] [Abstract][Full Text] [Related]
16. Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.
van Kleef LA; Ayada I; Alferink LJM; Pan Q; de Knegt RJ
Hepatology; 2022 Feb; 75(2):419-429. PubMed ID: 34453359
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
Da Silva HE; Arendt BM; Noureldin SA; Therapondos G; Guindi M; Allard JP
J Acad Nutr Diet; 2014 Aug; 114(8):1181-94. PubMed ID: 24631112
[TBL] [Abstract][Full Text] [Related]
18. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
[TBL] [Abstract][Full Text] [Related]
19. Metabolic dysfunction associated fatty liver disease (MAFLD) and serum vitamin D concentration in South Korea.
Lee HK; Shin SR; Han AL
Asia Pac J Clin Nutr; 2022; 31(2):201-207. PubMed ID: 35766555
[TBL] [Abstract][Full Text] [Related]
20. Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors.
Huang XJ; Yin M; Zhou BQ; Tan XY; Xia YQ; Qin CX
World J Hepatol; 2023 Aug; 15(8):985-1000. PubMed ID: 37701916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
